id	sid	tid	token	lemma	pos
dpc-3220	1	1	dermatology	dermatology	NOUN
dpc-3220	1	2	:	:	PUNCT
dpc-3220	1	3	practical	practical	ADJ
dpc-3220	1	4	and	and	CCONJ
dpc-3220	1	5	conceptual	conceptual	ADJ
dpc-3220	1	6	image	image	NOUN
dpc-3220	1	7	letter	letter	NOUN
dpc-3220	2	1	|	|	ADV
dpc-3220	2	2	dermatol	dermatol	ADJ
dpc-3220	2	3	pract	pract	NOUN
dpc-3220	2	4	concept	concept	NOUN
dpc-3220	2	5	.	.	PUNCT
dpc-3220	3	1	2023;13(4):e2023227	2023;13(4):e2023227	NUM
dpc-3220	3	2	1	1	NUM
dpc-3220	3	3	abscopal	abscopal	ADJ
dpc-3220	3	4	effect	effect	NOUN
dpc-3220	3	5	after	after	ADP
dpc-3220	3	6	localized	localized	ADJ
dpc-3220	3	7	radiotherapy	radiotherapy	NOUN
dpc-3220	3	8	in	in	ADP
dpc-3220	3	9	a	a	DET
dpc-3220	3	10	patient	patient	NOUN
dpc-3220	3	11	with	with	ADP
dpc-3220	3	12	sezary	sezary	ADJ
dpc-3220	3	13	syndrome	syndrome	NOUN
dpc-3220	3	14	under	under	ADP
dpc-3220	3	15	treatment	treatment	NOUN
dpc-3220	3	16	 	 	SPACE
dpc-3220	3	17	with	with	ADP
dpc-3220	3	18	mogamulizumab	mogamulizumab	PROPN
dpc-3220	3	19	vieri	vieri	PROPN
dpc-3220	3	20	grandi1	grandi1	PROPN
dpc-3220	3	21	,	,	PUNCT
dpc-3220	3	22	isabella	isabella	NOUN
dpc-3220	3	23	ciardetti1	ciardetti1	PROPN
dpc-3220	3	24	,	,	PUNCT
dpc-3220	3	25	andrea	andrea	PROPN
dpc-3220	3	26	gemignani1	gemignani1	PROPN
dpc-3220	3	27	,	,	PUNCT
dpc-3220	3	28	eleonora	eleonora	PROPN
dpc-3220	3	29	gherardi1	gherardi1	PROPN
dpc-3220	3	30	,	,	PUNCT
dpc-3220	3	31	tommaso	tommaso	PROPN
dpc-3220	3	32	 	 	SPACE
dpc-3220	3	33	grassi2	grassi2	NOUN
dpc-3220	3	34	,	,	PUNCT
dpc-3220	3	35	nicola	nicola	PROPN
dpc-3220	3	36	pimpinelli1	pimpinelli1	PROPN
dpc-3220	3	37	1	1	NUM
dpc-3220	3	38	department	department	PROPN
dpc-3220	3	39	of	of	ADP
dpc-3220	3	40	health	health	PROPN
dpc-3220	3	41	sciences	sciences	PROPN
dpc-3220	3	42	,	,	PUNCT
dpc-3220	3	43	section	section	NOUN
dpc-3220	3	44	of	of	ADP
dpc-3220	3	45	dermatology	dermatology	NOUN
dpc-3220	3	46	,	,	PUNCT
dpc-3220	3	47	university	university	NOUN
dpc-3220	3	48	of	of	ADP
dpc-3220	3	49	florence	florence	NOUN
dpc-3220	3	50	,	,	PUNCT
dpc-3220	3	51	p.	p.	PROPN
dpc-3220	3	52	palagi	palagi	PROPN
dpc-3220	3	53	hospital	hospital	PROPN
dpc-3220	3	54	,	,	PUNCT
dpc-3220	3	55	florence	florence	NOUN
dpc-3220	3	56	,	,	PUNCT
dpc-3220	3	57	italy	italy	PROPN
dpc-3220	3	58	2	2	NUM
dpc-3220	3	59	public	public	ADJ
dpc-3220	3	60	health	health	NOUN
dpc-3220	3	61	,	,	PUNCT
dpc-3220	3	62	hygiene	hygiene	NOUN
dpc-3220	3	63	and	and	CCONJ
dpc-3220	3	64	preventive	preventive	ADJ
dpc-3220	3	65	medicine	medicine	NOUN
dpc-3220	3	66	unit	unit	NOUN
dpc-3220	3	67	,	,	PUNCT
dpc-3220	3	68	p.	p.	PROPN
dpc-3220	3	69	palagi	palagi	PROPN
dpc-3220	3	70	hospital	hospital	PROPN
dpc-3220	3	71	,	,	PUNCT
dpc-3220	3	72	florence	florence	NOUN
dpc-3220	3	73	,	,	PUNCT
dpc-3220	3	74	italy	italy	PROPN
dpc-3220	3	75	citation	citation	PROPN
dpc-3220	3	76	:	:	PUNCT
dpc-3220	3	77	grandi	grandi	PROPN
dpc-3220	3	78	v	v	PROPN
dpc-3220	3	79	,	,	PUNCT
dpc-3220	3	80	ciardetti	ciardetti	PROPN
dpc-3220	3	81	i	i	PROPN
dpc-3220	3	82	,	,	PUNCT
dpc-3220	3	83	gemignani	gemignani	PROPN
dpc-3220	3	84	a	a	X
dpc-3220	3	85	,	,	PUNCT
dpc-3220	3	86	gherardi	gherardi	NOUN
dpc-3220	3	87	e	e	NOUN
dpc-3220	3	88	,	,	PUNCT
dpc-3220	3	89	grassi	grassi	PROPN
dpc-3220	3	90	t	t	PROPN
dpc-3220	3	91	,	,	PUNCT
dpc-3220	3	92	pimpinelli	pimpinelli	PROPN
dpc-3220	3	93	n.	n.	PROPN
dpc-3220	3	94	abscopal	abscopal	ADJ
dpc-3220	3	95	effect	effect	NOUN
dpc-3220	3	96	after	after	ADP
dpc-3220	3	97	localized	localized	ADJ
dpc-3220	3	98	radiotherapy	radiotherapy	NOUN
dpc-3220	3	99	in	in	ADP
dpc-3220	3	100	a	a	DET
dpc-3220	3	101	patient	patient	NOUN
dpc-3220	3	102	with	with	ADP
dpc-3220	3	103	sezary	sezary	ADJ
dpc-3220	3	104	syndrome	syndrome	NOUN
dpc-3220	3	105	under	under	ADP
dpc-3220	3	106	treatment	treatment	NOUN
dpc-3220	3	107	with	with	ADP
dpc-3220	3	108	mogamulizumab	mogamulizumab	NOUN
dpc-3220	3	109	.	.	PUNCT
dpc-3220	4	1	dermatol	dermatol	NOUN
dpc-3220	4	2	pract	pract	PROPN
dpc-3220	4	3	concept	concept	NOUN
dpc-3220	4	4	.	.	PUNCT
dpc-3220	5	1	2023;13(4):e2023227	2023;13(4):e2023227	X
dpc-3220	5	2	.	.	PUNCT
dpc-3220	5	3	doi	doi	PROPN
dpc-3220	5	4	:	:	PUNCT
dpc-3220	5	5	https://doi	https://doi	PROPN
dpc-3220	5	6	.org/10.5826	.org/10.5826	PROPN
dpc-3220	5	7	/	/	SYM
dpc-3220	5	8	dpc.1304a227	dpc.1304a227	PROPN
dpc-3220	5	9	accepted	accept	VERB
dpc-3220	5	10	:	:	PUNCT
dpc-3220	5	11	april	april	PROPN
dpc-3220	5	12	5	5	NUM
dpc-3220	5	13	,	,	PUNCT
dpc-3220	5	14	2023	2023	NUM
dpc-3220	5	15	;	;	PUNCT
dpc-3220	5	16	published	publish	VERB
dpc-3220	5	17	:	:	PUNCT
dpc-3220	6	1	october	october	PROPN
dpc-3220	6	2	2023	2023	NUM
dpc-3220	6	3	copyright	copyright	NOUN
dpc-3220	6	4	:	:	PUNCT
dpc-3220	6	5	©	©	PROPN
dpc-3220	6	6	2023	2023	NUM
dpc-3220	6	7	grandi	grandi	X
dpc-3220	6	8	et	et	PROPN
dpc-3220	6	9	al	al	PROPN
dpc-3220	6	10	.	.	PUNCT
dpc-3220	7	1	this	this	PRON
dpc-3220	7	2	is	be	AUX
dpc-3220	7	3	an	an	DET
dpc-3220	7	4	open	open	ADJ
dpc-3220	7	5	-	-	PUNCT
dpc-3220	7	6	access	access	NOUN
dpc-3220	7	7	article	article	NOUN
dpc-3220	7	8	distributed	distribute	VERB
dpc-3220	7	9	under	under	ADP
dpc-3220	7	10	the	the	DET
dpc-3220	7	11	terms	term	NOUN
dpc-3220	7	12	of	of	ADP
dpc-3220	7	13	the	the	DET
dpc-3220	7	14	creative	creative	ADJ
dpc-3220	7	15	commons	common	NOUN
dpc-3220	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3220	7	17	license	license	NOUN
dpc-3220	7	18	(	(	PUNCT
dpc-3220	7	19	by	by	ADP
dpc-3220	7	20	-	-	PUNCT
dpc-3220	7	21	nc-4.0	nc-4.0	NOUN
dpc-3220	7	22	)	)	PUNCT
dpc-3220	7	23	,	,	PUNCT
dpc-3220	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3220	7	25	,	,	PUNCT
dpc-3220	7	26	which	which	PRON
dpc-3220	7	27	permits	permit	VERB
dpc-3220	7	28	unrestricted	unrestricted	ADJ
dpc-3220	7	29	noncommercial	noncommercial	ADJ
dpc-3220	7	30	use	use	NOUN
dpc-3220	7	31	,	,	PUNCT
dpc-3220	7	32	distribution	distribution	NOUN
dpc-3220	7	33	,	,	PUNCT
dpc-3220	7	34	and	and	CCONJ
dpc-3220	7	35	reproduction	reproduction	NOUN
dpc-3220	7	36	in	in	ADP
dpc-3220	7	37	any	any	DET
dpc-3220	7	38	medium	medium	NOUN
dpc-3220	7	39	,	,	PUNCT
dpc-3220	7	40	provided	provide	VERB
dpc-3220	7	41	the	the	DET
dpc-3220	7	42	original	original	ADJ
dpc-3220	7	43	authors	author	NOUN
dpc-3220	7	44	and	and	CCONJ
dpc-3220	7	45	source	source	NOUN
dpc-3220	7	46	are	be	AUX
dpc-3220	7	47	credited	credit	VERB
dpc-3220	7	48	.	.	PUNCT
dpc-3220	8	1	funding	funding	NOUN
dpc-3220	8	2	:	:	PUNCT
dpc-3220	8	3	none	none	NOUN
dpc-3220	8	4	.	.	PUNCT
dpc-3220	9	1	competing	compete	VERB
dpc-3220	9	2	interests	interest	NOUN
dpc-3220	9	3	:	:	PUNCT
dpc-3220	9	4	none	none	NOUN
dpc-3220	9	5	.	.	PUNCT
dpc-3220	10	1	authorship	authorship	NOUN
dpc-3220	10	2	:	:	PUNCT
dpc-3220	10	3	all	all	DET
dpc-3220	10	4	authors	author	NOUN
dpc-3220	10	5	have	have	AUX
dpc-3220	10	6	contributed	contribute	VERB
dpc-3220	10	7	significantly	significantly	ADV
dpc-3220	10	8	to	to	ADP
dpc-3220	10	9	this	this	DET
dpc-3220	10	10	publication	publication	NOUN
dpc-3220	10	11	.	.	PUNCT
dpc-3220	11	1	corresponding	correspond	VERB
dpc-3220	11	2	author	author	NOUN
dpc-3220	11	3	:	:	PUNCT
dpc-3220	11	4	grandi	grandi	PROPN
dpc-3220	11	5	vieri	vieri	PROPN
dpc-3220	11	6	,	,	PUNCT
dpc-3220	11	7	department	department	PROPN
dpc-3220	11	8	of	of	ADP
dpc-3220	11	9	health	health	PROPN
dpc-3220	11	10	sciences	sciences	PROPN
dpc-3220	11	11	,	,	PUNCT
dpc-3220	11	12	section	section	NOUN
dpc-3220	11	13	of	of	ADP
dpc-3220	11	14	dermatology	dermatology	NOUN
dpc-3220	11	15	,	,	PUNCT
dpc-3220	11	16	university	university	NOUN
dpc-3220	11	17	of	of	ADP
dpc-3220	11	18	florence	florence	NOUN
dpc-3220	11	19	,	,	PUNCT
dpc-3220	11	20	p.	p.	PROPN
dpc-3220	11	21	palagi	palagi	PROPN
dpc-3220	11	22	hospital	hospital	PROPN
dpc-3220	11	23	,	,	PUNCT
dpc-3220	11	24	viale	viale	NOUN
dpc-3220	11	25	michelangelo	michelangelo	NOUN
dpc-3220	11	26	41	41	NUM
dpc-3220	11	27	,	,	PUNCT
dpc-3220	11	28	50141	50141	NUM
dpc-3220	11	29	,	,	PUNCT
dpc-3220	11	30	florence	florence	NOUN
dpc-3220	11	31	,	,	PUNCT
dpc-3220	11	32	italy	italy	PROPN
dpc-3220	11	33	.	.	PUNCT
dpc-3220	12	1	email	email	NOUN
dpc-3220	12	2	:	:	PUNCT
dpc-3220	12	3	vieri.grandi@unifi.it	vieri.grandi@unifi.it	ADJ
dpc-3220	12	4	case	case	NOUN
dpc-3220	12	5	presentation	presentation	NOUN
dpc-3220	12	6	a	a	DET
dpc-3220	12	7	50	50	NUM
dpc-3220	12	8	-	-	PUNCT
dpc-3220	12	9	year	year	NOUN
dpc-3220	12	10	-	-	PUNCT
dpc-3220	12	11	old	old	ADJ
dpc-3220	12	12	lady	lady	NOUN
dpc-3220	12	13	with	with	ADP
dpc-3220	12	14	sezary	sezary	ADJ
dpc-3220	12	15	syndrome	syndrome	NOUN
dpc-3220	12	16	(	(	PUNCT
dpc-3220	12	17	stage	stage	NOUN
dpc-3220	12	18	iva1	iva1	PROPN
dpc-3220	12	19	)	)	PUNCT
dpc-3220	12	20	,	,	PUNCT
dpc-3220	12	21	diagnosed	diagnose	VERB
dpc-3220	12	22	2	2	NUM
dpc-3220	12	23	years	year	NOUN
dpc-3220	12	24	before	before	ADV
dpc-3220	12	25	,	,	PUNCT
dpc-3220	12	26	had	have	AUX
dpc-3220	12	27	been	be	AUX
dpc-3220	12	28	treated	treat	VERB
dpc-3220	12	29	previously	previously	ADV
dpc-3220	12	30	with	with	ADP
dpc-3220	12	31	extracorporeal	extracorporeal	ADJ
dpc-3220	12	32	photophoresis	photophoresis	NOUN
dpc-3220	12	33	+	+	CCONJ
dpc-3220	12	34	interferon	interferon	ADJ
dpc-3220	12	35	-	-	PUNCT
dpc-3220	12	36	alfa	alfa	NOUN
dpc-3220	12	37	,	,	PUNCT
dpc-3220	12	38	methotrexate	methotrexate	NOUN
dpc-3220	12	39	,	,	PUNCT
dpc-3220	12	40	and	and	CCONJ
dpc-3220	12	41	gemcitabine	gemcitabine	NOUN
dpc-3220	12	42	.	.	PUNCT
dpc-3220	13	1	after	after	ADP
dpc-3220	13	2	12	12	NUM
dpc-3220	13	3	months	month	NOUN
dpc-3220	13	4	,	,	PUNCT
dpc-3220	13	5	we	we	PRON
dpc-3220	13	6	introduced	introduce	VERB
dpc-3220	13	7	mogamulizumab	mogamulizumab	ADP
dpc-3220	13	8	i.v	i.v	PROPN
dpc-3220	13	9	.	.	PUNCT
dpc-3220	14	1	after	after	ADP
dpc-3220	14	2	6	6	NUM
dpc-3220	14	3	cycles	cycle	NOUN
dpc-3220	14	4	,	,	PUNCT
dpc-3220	14	5	she	she	PRON
dpc-3220	14	6	achieved	achieve	VERB
dpc-3220	14	7	a	a	DET
dpc-3220	14	8	partial	partial	ADJ
dpc-3220	14	9	response	response	NOUN
dpc-3220	14	10	in	in	ADP
dpc-3220	14	11	the	the	DET
dpc-3220	14	12	skin	skin	NOUN
dpc-3220	14	13	,	,	PUNCT
dpc-3220	14	14	with	with	ADP
dpc-3220	14	15	only	only	ADV
dpc-3220	14	16	a	a	DET
dpc-3220	14	17	large	large	ADJ
dpc-3220	14	18	thick	thick	ADJ
dpc-3220	14	19	plaque	plaque	NOUN
dpc-3220	14	20	residual	residual	ADJ
dpc-3220	14	21	on	on	ADP
dpc-3220	14	22	the	the	DET
dpc-3220	14	23	back	back	NOUN
dpc-3220	14	24	(	(	PUNCT
dpc-3220	14	25	modified	modify	VERB
dpc-3220	14	26	severity	severity	NOUN
dpc-3220	14	27	assessment	assessment	NOUN
dpc-3220	14	28	tool	tool	NOUN
dpc-3220	14	29	,	,	PUNCT
dpc-3220	14	30	mswat	mswat	NOUN
dpc-3220	14	31	=	=	SYM
dpc-3220	14	32	  	  	SPACE
dpc-3220	14	33	8)	8)	NUM
dpc-3220	14	34	,	,	PUNCT
dpc-3220	14	35	and	and	CCONJ
dpc-3220	14	36	a	a	DET
dpc-3220	14	37	complete	complete	ADJ
dpc-3220	14	38	response	response	NOUN
dpc-3220	14	39	in	in	ADP
dpc-3220	14	40	the	the	DET
dpc-3220	14	41	blood	blood	NOUN
dpc-3220	14	42	.	.	PUNCT
dpc-3220	15	1	after	after	ADP
dpc-3220	15	2	two	two	NUM
dpc-3220	15	3	months	month	NOUN
dpc-3220	15	4	,	,	PUNCT
dpc-3220	15	5	her	her	PRON
dpc-3220	15	6	disease	disease	NOUN
dpc-3220	15	7	progressed	progress	VERB
dpc-3220	15	8	with	with	ADP
dpc-3220	15	9	bulky	bulky	ADJ
dpc-3220	15	10	nodal	nodal	NOUN
dpc-3220	15	11	involvement	involvement	NOUN
dpc-3220	15	12	in	in	ADP
dpc-3220	15	13	the	the	DET
dpc-3220	15	14	right	right	ADJ
dpc-3220	15	15	cervical	cervical	ADJ
dpc-3220	15	16	basin	basin	NOUN
dpc-3220	15	17	(	(	PUNCT
dpc-3220	15	18	iva2	iva2	PROPN
dpc-3220	15	19	)	)	PUNCT
dpc-3220	15	20	,	,	PUNCT
dpc-3220	15	21	treated	treat	VERB
dpc-3220	15	22	with	with	ADP
dpc-3220	15	23	palliative	palliative	ADJ
dpc-3220	15	24	surgery	surgery	NOUN
dpc-3220	15	25	.	.	PUNCT
dpc-3220	16	1	subsequently	subsequently	ADV
dpc-3220	16	2	,	,	PUNCT
dpc-3220	16	3	she	she	PRON
dpc-3220	16	4	developed	develop	VERB
dpc-3220	16	5	a	a	DET
dpc-3220	16	6	rapidly	rapidly	ADV
dpc-3220	16	7	growing	grow	VERB
dpc-3220	16	8	tender	tender	ADJ
dpc-3220	16	9	mass	mass	NOUN
dpc-3220	16	10	on	on	ADP
dpc-3220	16	11	the	the	DET
dpc-3220	16	12	occiput	occiput	NOUN
dpc-3220	16	13	.	.	PUNCT
dpc-3220	17	1	we	we	PRON
dpc-3220	17	2	decided	decide	VERB
dpc-3220	17	3	to	to	PART
dpc-3220	17	4	treat	treat	VERB
dpc-3220	17	5	it	it	PRON
dpc-3220	17	6	with	with	ADP
dpc-3220	17	7	electron	electron	NOUN
dpc-3220	17	8	radiotherapy	radiotherapy	NOUN
dpc-3220	17	9	(	(	PUNCT
dpc-3220	17	10	15	15	NUM
dpc-3220	17	11	gy	gy	NOUN
dpc-3220	17	12	in	in	ADP
dpc-3220	17	13	5	5	NUM
dpc-3220	17	14	fractions	fraction	NOUN
dpc-3220	17	15	)	)	PUNCT
dpc-3220	17	16	,	,	PUNCT
dpc-3220	17	17	obtaining	obtain	VERB
dpc-3220	17	18	rapid	rapid	ADJ
dpc-3220	17	19	local	local	ADJ
dpc-3220	17	20	control	control	NOUN
dpc-3220	17	21	.	.	PUNCT
dpc-3220	18	1	after	after	ADP
dpc-3220	18	2	a	a	DET
dpc-3220	18	3	few	few	ADJ
dpc-3220	18	4	weeks	week	NOUN
dpc-3220	18	5	from	from	ADP
dpc-3220	18	6	the	the	DET
dpc-3220	18	7	scalp	scalp	NOUN
dpc-3220	18	8	irradiation	irradiation	NOUN
dpc-3220	18	9	,	,	PUNCT
dpc-3220	18	10	the	the	DET
dpc-3220	18	11	large	large	ADJ
dpc-3220	18	12	plaque	plaque	NOUN
dpc-3220	18	13	on	on	ADP
dpc-3220	18	14	the	the	DET
dpc-3220	18	15	back	back	NOUN
dpc-3220	18	16	disappeared	disappear	VERB
dpc-3220	18	17	,	,	PUNCT
dpc-3220	18	18	leaving	leave	VERB
dpc-3220	18	19	a	a	DET
dpc-3220	18	20	hyperpigmented	hyperpigmented	ADJ
dpc-3220	18	21	area	area	NOUN
dpc-3220	18	22	.	.	PUNCT
dpc-3220	19	1	teaching	teaching	NOUN
dpc-3220	19	2	point	point	NOUN
dpc-3220	19	3	the	the	DET
dpc-3220	19	4	abscopal	abscopal	ADJ
dpc-3220	19	5	effect	effect	NOUN
dpc-3220	19	6	refers	refer	VERB
dpc-3220	19	7	to	to	ADP
dpc-3220	19	8	an	an	DET
dpc-3220	19	9	uncommon	uncommon	ADJ
dpc-3220	19	10	activation	activation	NOUN
dpc-3220	19	11	of	of	ADP
dpc-3220	19	12	the	the	DET
dpc-3220	19	13	immune	immune	ADJ
dpc-3220	19	14	system	system	NOUN
dpc-3220	19	15	secondary	secondary	ADJ
dpc-3220	19	16	to	to	ADP
dpc-3220	19	17	radiotherapy	radiotherapy	NOUN
dpc-3220	19	18	that	that	PRON
dpc-3220	19	19	may	may	AUX
dpc-3220	19	20	lead	lead	VERB
dpc-3220	19	21	to	to	ADP
dpc-3220	19	22	clinical	clinical	ADJ
dpc-3220	19	23	responses	response	NOUN
dpc-3220	19	24	in	in	ADP
dpc-3220	19	25	areas	area	NOUN
dpc-3220	19	26	far	far	ADV
dpc-3220	19	27	from	from	ADP
dpc-3220	19	28	the	the	DET
dpc-3220	19	29	irradiation	irradiation	NOUN
dpc-3220	19	30	site	site	NOUN
dpc-3220	19	31	  	  	SPACE
dpc-3220	20	1	[	[	X
dpc-3220	20	2	1	1	NUM
dpc-3220	20	3	]	]	PUNCT
dpc-3220	20	4	.	.	PUNCT
dpc-3220	21	1	mogamulizumab	mogamulizumab	PROPN
dpc-3220	21	2	is	be	AUX
dpc-3220	21	3	a	a	DET
dpc-3220	21	4	defucosylated	defucosylated	ADJ
dpc-3220	21	5	,	,	PUNCT
dpc-3220	21	6	humanized	humanize	VERB
dpc-3220	21	7	igg1	igg1	NOUN
dpc-3220	21	8	kappa	kappa	PROPN
dpc-3220	21	9	immunoglobulin	immunoglobulin	PROPN
dpc-3220	21	10	selective	selective	NOUN
dpc-3220	21	11	against	against	ADP
dpc-3220	21	12	cc	cc	NOUN
dpc-3220	21	13	receptor	receptor	NOUN
dpc-3220	21	14	type	type	NOUN
dpc-3220	21	15	4	4	NUM
dpc-3220	21	16	(	(	PUNCT
dpc-3220	21	17	ccr4	ccr4	NOUN
dpc-3220	21	18	)	)	PUNCT
dpc-3220	21	19	.	.	PUNCT
dpc-3220	22	1	it	it	PRON
dpc-3220	22	2	binds	bind	VERB
dpc-3220	22	3	directly	directly	ADV
dpc-3220	22	4	to	to	ADP
dpc-3220	22	5	ccr4	ccr4	PROPN
dpc-3220	22	6	expressed	express	VERB
dpc-3220	22	7	on	on	ADP
dpc-3220	22	8	tumor	tumor	NOUN
dpc-3220	22	9	cells	cell	NOUN
dpc-3220	22	10	,	,	PUNCT
dpc-3220	22	11	yet	yet	CCONJ
dpc-3220	22	12	it	it	PRON
dpc-3220	22	13	is	be	AUX
dpc-3220	22	14	also	also	ADV
dpc-3220	22	15	known	know	VERB
dpc-3220	22	16	to	to	PART
dpc-3220	22	17	exert	exert	VERB
dpc-3220	22	18	indirect	indirect	ADJ
dpc-3220	22	19	immunemediated	immunemediate	VERB
dpc-3220	22	20	antitumor	antitumor	PROPN
dpc-3220	22	21	effects	effect	NOUN
dpc-3220	22	22	via	via	ADP
dpc-3220	22	23	inhibition	inhibition	NOUN
dpc-3220	22	24	of	of	ADP
dpc-3220	22	25	ccr4	ccr4	NOUN
dpc-3220	22	26	on	on	ADP
dpc-3220	22	27	tregs	treg	NOUN
dpc-3220	22	28	[	[	X
dpc-3220	22	29	2	2	NUM
dpc-3220	22	30	]	]	PUNCT
dpc-3220	22	31	.	.	PUNCT
dpc-3220	23	1	rapid	rapid	ADJ
dpc-3220	23	2	lysis	lysis	NOUN
dpc-3220	23	3	of	of	ADP
dpc-3220	23	4	tumor	tumor	NOUN
dpc-3220	23	5	cells	cell	NOUN
dpc-3220	23	6	induced	induce	VERB
dpc-3220	23	7	by	by	ADP
dpc-3220	23	8	radiotherapy	radiotherapy	NOUN
dpc-3220	23	9	,	,	PUNCT
dpc-3220	23	10	alongside	alongside	ADP
dpc-3220	23	11	the	the	DET
dpc-3220	23	12	positive	positive	ADJ
dpc-3220	23	13	immune	immune	ADJ
dpc-3220	23	14	activation	activation	NOUN
dpc-3220	23	15	induced	induce	VERB
dpc-3220	23	16	by	by	ADP
dpc-3220	23	17	mogamulizumab	mogamulizumab	ADV
dpc-3220	23	18	,	,	PUNCT
dpc-3220	23	19	might	might	AUX
dpc-3220	23	20	explain	explain	VERB
dpc-3220	23	21	the	the	DET
dpc-3220	23	22	impressive	impressive	ADJ
dpc-3220	23	23	response	response	NOUN
dpc-3220	23	24	obtained	obtain	VERB
dpc-3220	23	25	in	in	ADP
dpc-3220	23	26	a	a	DET
dpc-3220	23	27	large	large	ADJ
dpc-3220	23	28	,	,	PUNCT
dpc-3220	23	29	refractory	refractory	NOUN
dpc-3220	23	30	skin	skin	NOUN
dpc-3220	23	31	plaque	plaque	NOUN
dpc-3220	23	32	in	in	ADP
dpc-3220	23	33	our	our	PRON
dpc-3220	23	34	patient	patient	NOUN
dpc-3220	23	35	.	.	PUNCT
dpc-3220	24	1	we	we	PRON
dpc-3220	24	2	believe	believe	VERB
dpc-3220	24	3	that	that	SCONJ
dpc-3220	24	4	mogamulizumab	mogamulizumab	VERB
dpc-3220	24	5	combined	combine	VERB
dpc-3220	24	6	with	with	ADP
dpc-3220	24	7	radiotherapy	radiotherapy	NOUN
dpc-3220	24	8	is	be	AUX
dpc-3220	24	9	an	an	DET
dpc-3220	24	10	interesting	interesting	ADJ
dpc-3220	24	11	approach	approach	NOUN
dpc-3220	24	12	in	in	ADP
dpc-3220	24	13	patients	patient	NOUN
dpc-3220	24	14	with	with	ADP
dpc-3220	24	15	cutaneous	cutaneous	ADJ
dpc-3220	24	16	t	t	PROPN
dpc-3220	24	17	-	-	PUNCT
dpc-3220	24	18	cell	cell	NOUN
dpc-3220	24	19	lymphoma	lymphoma	NOUN
dpc-3220	24	20	,	,	PUNCT
dpc-3220	24	21	yet	yet	CCONJ
dpc-3220	24	22	further	further	ADJ
dpc-3220	24	23	studies	study	NOUN
dpc-3220	24	24	are	be	AUX
dpc-3220	24	25	needed	need	VERB
dpc-3220	24	26	in	in	ADP
dpc-3220	24	27	order	order	NOUN
dpc-3220	24	28	to	to	PART
dpc-3220	24	29	better	well	ADV
dpc-3220	24	30	explain	explain	VERB
dpc-3220	24	31	the	the	DET
dpc-3220	24	32	reported	report	VERB
dpc-3220	24	33	abscopal	abscopal	ADJ
dpc-3220	24	34	effect	effect	NOUN
dpc-3220	24	35	.	.	PUNCT
dpc-3220	25	1	2	2	NUM
dpc-3220	25	2	image	image	NOUN
dpc-3220	25	3	letter	letter	NOUN
dpc-3220	25	4	|	|	ADV
dpc-3220	25	5	dermatol	dermatol	ADJ
dpc-3220	25	6	pract	pract	NOUN
dpc-3220	25	7	concept	concept	NOUN
dpc-3220	25	8	.	.	PUNCT
dpc-3220	26	1	2023;13(4):e2023227	2023;13(4):e2023227	NUM
dpc-3220	26	2	2	2	NUM
dpc-3220	26	3	.	.	PUNCT
dpc-3220	26	4	kim	kim	PROPN
dpc-3220	26	5	yh	yh	PROPN
dpc-3220	26	6	,	,	PUNCT
dpc-3220	26	7	bagot	bagot	PROPN
dpc-3220	26	8	m	m	PROPN
dpc-3220	26	9	,	,	PUNCT
dpc-3220	26	10	pinter	pinter	NOUN
dpc-3220	26	11	-	-	PUNCT
dpc-3220	26	12	brown	brown	NOUN
dpc-3220	26	13	l	l	NOUN
dpc-3220	26	14	,	,	PUNCT
dpc-3220	26	15	et	et	PROPN
dpc-3220	26	16	al	al	PROPN
dpc-3220	26	17	.	.	PROPN
dpc-3220	26	18	mogamulizumab	mogamulizumab	PROPN
dpc-3220	26	19	versus	versus	ADP
dpc-3220	26	20	vorinostat	vorinostat	NOUN
dpc-3220	26	21	in	in	ADP
dpc-3220	26	22	previously	previously	ADV
dpc-3220	26	23	treated	treat	VERB
dpc-3220	26	24	cutaneous	cutaneous	ADJ
dpc-3220	26	25	t	t	PROPN
dpc-3220	26	26	-	-	PUNCT
dpc-3220	26	27	cell	cell	NOUN
dpc-3220	26	28	lymphoma	lymphoma	NOUN
dpc-3220	26	29	(	(	PUNCT
dpc-3220	26	30	mavoric	mavoric	NOUN
dpc-3220	26	31	):	):	PUNCT
dpc-3220	26	32	an	an	DET
dpc-3220	26	33	international	international	ADJ
dpc-3220	26	34	,	,	PUNCT
dpc-3220	26	35	open	open	ADJ
dpc-3220	26	36	-	-	PUNCT
dpc-3220	26	37	label	label	NOUN
dpc-3220	26	38	,	,	PUNCT
dpc-3220	26	39	randomised	randomise	VERB
dpc-3220	26	40	,	,	PUNCT
dpc-3220	26	41	controlled	control	VERB
dpc-3220	26	42	phase	phase	NOUN
dpc-3220	26	43	3	3	NUM
dpc-3220	26	44	trial	trial	NOUN
dpc-3220	26	45	.	.	PUNCT
dpc-3220	27	1	lancet	lancet	PROPN
dpc-3220	27	2	oncol	oncol	ADJ
dpc-3220	27	3	2018;19:1192–204.image	2018;19:1192–204.image	NUM
dpc-3220	27	4	letter	letter	NOUN
dpc-3220	27	5	references	reference	NOUN
dpc-3220	27	6	1	1	NUM
dpc-3220	27	7	.	.	PUNCT
dpc-3220	28	1	yilmaz	yilmaz	PROPN
dpc-3220	28	2	mt	mt	PROPN
dpc-3220	28	3	,	,	PUNCT
dpc-3220	28	4	elmali	elmali	VERB
dpc-3220	28	5	a	a	PRON
dpc-3220	28	6	,	,	PUNCT
dpc-3220	28	7	yazici	yazici	NOUN
dpc-3220	28	8	g.	g.	PROPN
dpc-3220	28	9	abscopal	abscopal	PROPN
dpc-3220	28	10	effect	effect	PROPN
dpc-3220	28	11	,	,	PUNCT
dpc-3220	28	12	from	from	ADP
dpc-3220	28	13	myth	myth	NOUN
dpc-3220	28	14	to	to	ADP
dpc-3220	28	15	reality	reality	NOUN
dpc-3220	28	16	:	:	PUNCT
dpc-3220	28	17	from	from	ADP
dpc-3220	28	18	radiation	radiation	NOUN
dpc-3220	28	19	oncologists	oncologist	NOUN
dpc-3220	28	20	’	'	PUNCT
dpc-3220	28	21	perspective	perspective	NOUN
dpc-3220	28	22	.	.	PUNCT
dpc-3220	29	1	cureus	cureus	NOUN
dpc-3220	29	2	2019;11	2019;11	NUM
dpc-3220	29	3	:	:	PUNCT
dpc-3220	29	4	e3860	e3860	PROPN
dpc-3220	29	5	.	.	PUNCT
dpc-3220	29	6	figure	figure	NOUN
dpc-3220	29	7	1	1	NUM
dpc-3220	29	8	.	.	PUNCT
dpc-3220	30	1	clinical	clinical	ADJ
dpc-3220	30	2	photos	photo	NOUN
dpc-3220	30	3	of	of	ADP
dpc-3220	30	4	a	a	DET
dpc-3220	30	5	50	50	NUM
dpc-3220	30	6	-	-	PUNCT
dpc-3220	30	7	year	year	NOUN
dpc-3220	30	8	-	-	PUNCT
dpc-3220	30	9	old	old	ADJ
dpc-3220	30	10	lady	lady	NOUN
dpc-3220	30	11	affected	affect	VERB
dpc-3220	30	12	by	by	ADP
dpc-3220	30	13	sezary	sezary	ADJ
dpc-3220	30	14	syndrome	syndrome	NOUN
dpc-3220	30	15	with	with	ADP
dpc-3220	30	16	mogamulizumab	mogamulizumab	ADJ
dpc-3220	30	17	-	-	PUNCT
dpc-3220	30	18	refractory	refractory	NOUN
dpc-3220	30	19	skin	skin	NOUN
dpc-3220	30	20	lesions	lesion	NOUN
dpc-3220	30	21	.	.	PUNCT
dpc-3220	31	1	a	a	DET
dpc-3220	31	2	)	)	PUNCT
dpc-3220	31	3	rapidly	rapidly	ADV
dpc-3220	31	4	growing	grow	VERB
dpc-3220	31	5	,	,	PUNCT
dpc-3220	31	6	painful	painful	ADJ
dpc-3220	31	7	tumor	tumor	NOUN
dpc-3220	31	8	mass	mass	NOUN
dpc-3220	31	9	on	on	ADP
dpc-3220	31	10	the	the	DET
dpc-3220	31	11	scalp	scalp	NOUN
dpc-3220	31	12	.	.	PUNCT
dpc-3220	32	1	b	b	X
dpc-3220	32	2	)	)	PUNCT
dpc-3220	32	3	same	same	ADJ
dpc-3220	32	4	lesion	lesion	NOUN
dpc-3220	32	5	,	,	PUNCT
dpc-3220	32	6	45	45	NUM
dpc-3220	32	7	days	day	NOUN
dpc-3220	32	8	after	after	ADP
dpc-3220	32	9	electron	electron	NOUN
dpc-3220	32	10	-	-	PUNCT
dpc-3220	32	11	beam	beam	NOUN
dpc-3220	32	12	radiotherapy	radiotherapy	NOUN
dpc-3220	32	13	(	(	PUNCT
dpc-3220	32	14	15	15	NUM
dpc-3220	32	15	gy	gy	NOUN
dpc-3220	32	16	in	in	ADP
dpc-3220	32	17	5	5	NUM
dpc-3220	32	18	fractions	fraction	NOUN
dpc-3220	32	19	)	)	PUNCT
dpc-3220	32	20	.	.	PUNCT
dpc-3220	33	1	c	c	X
dpc-3220	33	2	)	)	PUNCT
dpc-3220	33	3	large	large	ADJ
dpc-3220	33	4	infiltrated	infiltrate	VERB
dpc-3220	33	5	,	,	PUNCT
dpc-3220	33	6	pruritic	pruritic	ADJ
dpc-3220	33	7	plaque	plaque	NOUN
dpc-3220	33	8	on	on	ADP
dpc-3220	33	9	the	the	DET
dpc-3220	33	10	back	back	NOUN
dpc-3220	33	11	.	.	PUNCT
dpc-3220	34	1	d	d	X
dpc-3220	34	2	)	)	PUNCT
dpc-3220	34	3	asymptomatic	asymptomatic	ADJ
dpc-3220	34	4	,	,	PUNCT
dpc-3220	34	5	postinflammatory	postinflammatory	PROPN
dpc-3220	34	6	hyperand	hyperand	NOUN
dpc-3220	34	7	hypopigmented	hypopigmente	VERB
dpc-3220	34	8	macules	macule	NOUN
dpc-3220	34	9	as	as	ADP
dpc-3220	34	10	result	result	NOUN
dpc-3220	34	11	of	of	ADP
dpc-3220	34	12	the	the	DET
dpc-3220	34	13	complete	complete	ADJ
dpc-3220	34	14	spontaneous	spontaneous	ADJ
dpc-3220	34	15	resolution	resolution	NOUN
dpc-3220	34	16	of	of	ADP
dpc-3220	34	17	the	the	DET
dpc-3220	34	18	lesion	lesion	NOUN